Supply Chain
Long wait times, crowded waiting rooms, and frustrated staff are often symptoms of inefficient workflows driven by physical space constraints.…
GlaxoSmithKline on Friday earned Food and Drug Administration approval for its shingles vaccine Shingrix.
Here are seven drug and medical device companies that made headlines in the past week.
Merck on Friday announced plans to cut 1,800 sales positions in the U.S., reports Reuters.
Introducing biosimilar versions of complex drugs into the marketplace could cut U.S. healthcare spending by $54 billion over the next 10 years, according to an analysis conducted by the RAND Corp.
The FDA isn't doing enough to regulate health and wellness mobile apps, which are becoming increasingly popular for developers and the general population, medical media expert at Houston-based Rice University Kirsten Ostherr, PhD, told Science Daily.
The Food and Drug Administration is monitoring dozens of medical devices produced in Puerto Rico for potential shortage risks, according to FDA Commissioner Scott Gottlieb, MD.
Here are the five latest drugs and medical devices approved by the Food and Drug Administration in the past week.
Dr. Reddy's Laboratories recalled more than 500,000 bottles of 10-milligram famotidine tablets Oct. 3, reports Business Standard.
Ten to 20 percent of pharmaceutical companies are shifting their advertising focus away from digital media and instead directing it toward the point-of-care, according to a recent analysis conducted by ZS Associates.
Here are seven articles Becker's Hospital Review published in the last week, highlighting Baxter's temporary shortage of small saline bags, Amneal Pharmaceutical's merger with Impax Laboratories and more.